Vaxart Inc (VXRT) support and resistance · rev $28.7M
Vaxart Inc (VXRT) is a biotechnology company listed on US.
This page maps Vaxart Inc (VXRT) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported VXRT revenue for 2024-12-31 was $28.7M. Net income was -$66.9M. Revenue was up 288.9% from 2023-12-31 to 2024-12-31. VXRT currently screens at market cap $73.0M.
VXRT currently screens at market cap $73.0M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new VXRT 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the VXRT quote page for the session range and the stock page for the full model.
Not investment advice.